(Q82826313)
Statements
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study (English)
Reinier O Schlingemann
Jean-François Korobelnik
Bora Eldem
Ruth Axer-Siegel
Peter Wiedemann
Margarita Gekkieva
Andreas Weichselberger
EXCITE Study Group
13 December 2010